News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
ESHO and AORTIC signed a Memorandum Understanding strengthen commitment for improving cancer control – Luca Incrocci Foundation
Collage of ESHO and AORTIC
Oct 1, 2024, 10:30

ESHO and AORTIC signed a Memorandum Understanding strengthen commitment for improving cancer control – Luca Incrocci Foundation

“In August 2024, the Ethiopian Society of Haematology and Oncology (ESHO) and the African Organization for Research and Training in Cancer (AORTIC) signed a Memorandum of Understanding (MOU), to strengthen their common commitment for improving cancer control, and patient outcomes.

This MOU expands AORTIC’s partnership and collaboration as an oncology workforce, enhancing support to country-specific cancer societies.

Dr Munir Awol (left), ESHO President and Dr Miriam Mutebi, AORTIC President in Addis Ababa, August 2024.”

Luca Incrocci Foundation

Source:

Addis Ababa African Organization for Research and Training in Cancer AORTIC cancer Cancer Control cancer societies ESHO Ethiopian Society of Haematology and Oncology Luca Incrocci Foundation memorandum of understanding Miriam Mutebi Munir Awol OncoDaily Oncology
Special Coverage
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research
Blog
Jan 20, 2025, 02:54
Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach
Science
Jan 20, 2025, 02:44
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Science
Jan 20, 2025, 02:16
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Blog
Jan 20, 2025, 02:14
Akriti Jain: Grateful to present at Cleveland Clinic ASH review
Career
Jan 19, 2025, 23:12
Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era